1. |
Walsh S, Lowery AJ, Evoy D, et al. Thyroid lymphoma: recent advances in diagnosis and optimal management strategies. Oncologist, 2013, 18(9): 994-1003.
|
2. |
Stein SA, Wartofsky L. Primary thyroid lymphoma: a clinical review. J Clin Endocrinol Metab, 2013, 98(8): 3131-3138.
|
3. |
Chai YJ, Hong JH, Koo do H, et al. Clinicopathological characteristics and treatment outcomes of 38 cases of primary thyroid lymphoma: a multicenter study. Ann Surg Treat Res, 2015, 89(6): 295-299.
|
4. |
Watanabe N, Noh JY, Narimatsu H, et al. Clinicopathological features of 171 cases of primary thyroid lymphoma: a long-term study involving 24 553 patients with Hashimoto’s disease. Br J Haematol, 2011, 153(2): 236-243.
|
5. |
Sarinah B, Hisham AN. Primary lymphoma of the thyroid: diagnostic and therapeutic considerations. Asian J Surg, 2010, 33(1): 20-24.
|
6. |
Czopnik P, Aporowicz M, Niepokój-Czopnik A, et al. Primary thyroid lymphoma: a rare but challenging diagnosis. Pol Arch Intern Med, 2017, 127(5): 361-364.
|
7. |
Sharma A, Jasim S, Reading CC, et al. Clinical presentation and diagnostic challenges of thyroid lymphoma: a cohort study. Thyroid, 2016, 26(8): 1061-1067.
|
8. |
Moghaddasi M, Nabovvati M, Razmeh S. Bilateral cavernous sinus thrombosis as first manifestation of primary burkitt lymphoma of the thyroid gland. Neurol Int, 2017, 9(2): 7133.
|
9. |
Green LD, Mack L, Pasieka JL. Anaplastic thyroid cancer and primary thyroid lymphoma: a review of these rare thyroid malignancies. J Surg Oncol, 2006, 94(8): 725-736.
|
10. |
Jaffe ES. The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematology Am Soc Hematol Educ Program, 2009: 523-531.
|
11. |
Alzouebi M, Goepel JR, Horsman JM, et al. Primary thyroid lymphoma: the 40 year experience of a UK lymphoma treatment centre. Int J Oncol, 2012, 40(6): 2075-2080.
|
12. |
Onal C, Li YX, Miller RC, et al. Treatment results and prognostic factors in primary thyroid lymphoma patients: a rare cancer network study. Ann Oncol, 2011, 22(1): 156-164.
|
13. |
Yahaya N, Din SW, Ghazali MZ, et al. Primary thyroid lymphoma with elevated free thyroxine level. Singapore Med J, 2011, 52(9): e173-e176.
|
14. |
Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 2016, 26(1): 1-133.
|
15. |
张秀梅, 农琳, 冉旭, 等. 甲状腺淋巴瘤临床病理及超声特征分析. 中华医学杂志, 2017, 97(37): 2936-2939.
|
16. |
Hirokawa M, Kudo T, Ota H, et al. Errata: preoperative diagnostic algorithm of primary thyroid lymphoma using ultrasound, aspiration cytology, and flow cytometry [Endocrine Journal Vol. 64 (9): 859-865, 2017]. Endocr J, 2017, 64(10): 1041-1042.
|
17. |
Wang JH, Chen L, Ren K. Identification of primary thyroid lymphoma with medical imaging: a case report and review of the literature. Oncol Lett, 2014, 8(6): 2505-2508.
|
18. |
Nakadate M, Yoshida K, Ishii A, et al. Is 18F-FDG PET/CT useful for distinguishing between primary thyroid lymphoma and chronic thyroiditis? Clin Nucl Med, 2013, 38(9): 709-714.
|
19. |
Spielman DB, Badhey A, Kadakia S, et al. Rare thyroid malig- nancies: an overview for the oncologist. Clin Oncol (R Coll Radiol), 2017, 29(5): 298-306.
|
20. |
Sakorafas GH, Kokkoris P, Farley DR. Primary thyroid lymphoma (correction of lympoma): diagnostic and therapeutic dilemmas. Surg Oncol, 2010, 19(4): e124-e129.
|
21. |
Adamczewski Z, Stasiołek M, Dedecjus M, et al. Flow cytometry in the differential diagnostics of Hashimoto’s thyroiditis and MALT lymphoma of the thyroid. Endokrynol Pol, 2015, 66(1): 73-78.
|
22. |
Graff-Baker A, Roman SA, Thomas DC, et al. Prognosis of primary thyroid lymphoma: demographic, clinical, and pathologic predictors of survival in 1,408 cases. Surgery, 2009, 146(6): 1105-1115.
|
23. |
Fujii H, Nakadate M, Tanaka H, et al. Residual FDG uptake of primary thyroid lymphoma after treatment may overestimate residual lymphoma. Ann Nucl Med, 2016, 30(10): 756-759.
|
24. |
Sakorafas GH. What’s the role of surgery in the management of primary thyroid lymphoma? Acta Oncol, 2011, 50(2): 319-320.
|
25. |
Chen C, Tibbetts KM, Tassler AB, et al. Tracheal invasion and perforation from advanced primary thyroid lymphoma: a case report and literature review. Am J Otolaryngol, 2013, 34(5): 559-562.
|
26. |
Harrington KJ, Michalaki VJ, Vini L, et al. Management of non-Hodgkin’s lymphoma of the thyroid: the Royal Marsden Hospital experience. Br J Radiol, 2005, 78(929): 405-410.
|
27. |
梁鹏, 王森, 陈康兵, 等. 原发性甲状腺恶性淋巴瘤的诊治及进展. 中华耳鼻咽喉头颈外科杂志, 2016, 51(4): 313-316.
|
28. |
Dai CW, Zhang GS, Pei MF, et al. Thyroid diffuse large B cell lymphoma (DLBCL) following thyroid medullary cancer: long-term complete remission with R-CHOP therapy. Ann Hematol, 2009, 88(7): 701-702.
|
29. |
Jonak C, Troch M, Müllauer L, et al. Rituximab plus dose-reduced cyclophosphamide, mitoxantrone, vincristine, and prednisolone are effective in elderly patients with diffuse large B-cell lymphoma of the thyroid. Thyroid, 2010, 20(4): 425-427.
|
30. |
Karlin L, Coiffier B. Improving survival and preventing recurrence of diffuse large B-cell lymphoma in younger patients: current strategies and future directions. Onco Targets Ther, 2013, 6: 289-296.
|
31. |
Visco C, Tzankov A, Xu-Monette ZY, et al. Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study. Haematologica, 2013, 98(2): 255-263.
|
32. |
Aggarwal N, Swerdlow SH, Kelly LM, et al. Thyroid carcinoma-associated genetic mutations also occur in thyroid lymphomas. Mod Pathol, 2012, 25(9): 1203-1211.
|
33. |
Ishibashi N, Maebayashi T, Aizawa T, et al. Radiation therapy for cutaneous blastic plasmacytoid dendritic cell neoplasm: a case report and review of the literature. Int J Clin Exp Med, 2015, 8(5): 8204-8209.
|
34. |
Ishibashi N, Maebayashi T, Aizawa T, et al. Hypothyroidism after radiotherapy for primary thyroid lymphoma. Anticancer Res, 2014, 34(8): 4427-4431.
|